scispace - formally typeset
P

Paul B. Fisher

Researcher at Virginia Commonwealth University

Publications -  486
Citations -  35304

Paul B. Fisher is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Cancer & Cancer cell. The author has an hindex of 80, co-authored 449 publications receiving 31149 citations. Previous affiliations of Paul B. Fisher include Discovery Institute & Columbia University Medical Center.

Papers
More filters
Journal ArticleDOI

Emerging roles of centrosomal amplification and genomic instability in cancer.

TL;DR: In this review, the recent studies investigating genomic instability and aneuploidy in human cancer, centrosome amplification and the role of centrosomal duplication in chromosomal mis-segregetion, and genes implicated in regulating chromosome segregation,Centrosomal amplification and progression in cancer cells are discussed.
Journal ArticleDOI

Emerging strategies for the early detection and prevention of head and neck squamous cell cancer

TL;DR: Recent advances in understanding of the molecular biology and etiology of HNSCC should facilitate development of improved intervention and therapeutic approaches and the potential role of such factors for developing preventive and early diagnostic strategies for H NSCC management is discussed.
Journal ArticleDOI

mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM.

TL;DR: A novel pathway for mda-7/IL-24-induced caspase-independent apoptosis in neuroblastoma cells is elucidated through modulation of AIF, ATM, and γ-H2AX, which was validated further using two ATM small-molecule inhibitors.
Journal ArticleDOI

A Serotype 5/3 Adenovirus Expressing MDA-7/IL-24 Infects Renal Carcinoma Cells and Promotes Toxicity of Agents That Increase Ros and Ceramide Levels

TL;DR: The data indicate that in RCCs, Ad.5/3-mda-7-induced ceramide generation plays a central role in tumor cell killing and inhibition of multiple signaling pathways may have utility in promoting MDA-7/IL-24 lethality in renal cancer.
Journal ArticleDOI

Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.

TL;DR: Findings support an effective dual-combinatorial approach for the therapy of colorectal cancers that employs a unique cancer-specific suppressor gene (mda-7/IL-24) with targeted inhibition of oncogene (ras) expression.